You are here

PORTABLE ULTRASONOMETER for OSTEOPOROSIS ASSESSMENT

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: N/A
Agency Tracking Number: 2R44AG017400-02
Amount: $589,972.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2001
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
1753 LINVALE HARBOURTON RD
LAMBERTVILLE, NJ 08530
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 ARMEN SARVAZYAN
 () -
Business Contact
Phone: (609) 333-0710
Email: ARMEN@PLUTO.NJCC.COM
Research Institution
N/A
Abstract

DESCRIPTION (Provided by Applicant): The aim of this project is to develop a
portable, low cost, fast and easy-to-use device for the quantitative assessment
of bone quality that is suitable for mass screening and early identification of
those at risk for osteoporosis. The device will detect changes in the
composition and micro-architectural properties of bone by measuring the
ultrasound velocity, attenuation, spectral, and non-linear acoustic (NLA)
parameters of bone at multiple sites along the skeleton with varied proportion
of spongy and compact bone components. The manual scanning probe operating in
surface pulse transmission mode will be used to obtain ultrasonic profiles in
tested skeletal area. The diagnostic potential of NLA spectroscopy as a novel
method for detecting the accumulation of microdamage in living bone will be
evaluated. The feasibility of the proposed methods and devices has been proven
in laboratory model studies and in pilot clinical trials. In Phase II of the
project designed during Phase I will be developed into a fully functional and
compact bone ultrasonometer with the manual scanning and NLA modes of
operation, and clinically tested. Indexes of bone quality composed of several
ultrasonic parameters will be developed for differential diagnostics of
osteoporosis and mixed osteopenia.
PROPOSED COMMERCIAL APPLICATIONS:
Early evaluation and monitoring of osteoporosis is imperative for timely and effective
treatment of the disease. According to the National Osteoporosis Foundation [1998 Report]
the current economic burden associated with osteoporosis-related fractures is estimated
at about $13.8 billion annually. There is an urgent need for advancement of the existing
diagnostic techniques. The Proposed multi-site ultrasonometer offers higher diagnostic
efficacy and specificity, lower cost, portability, and ease of operation. Developed device is
ideally suited for the mass screening of osteoporosis and primary monitoring of population
with high fracture risk.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government